DNA Topoisomerase II in Therapy-Related Acute Promyelocytic Leukemia

Abstract

Drug-induced cleavage of DNA by topoisomerase II mediates the formation of chromosomal translocation breakpoints in mitoxantrone-related APL and in APL that occurs after therapy with other topoisomerase II poisons.